Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
2,770
Funds Holding Change
0
Funds Holding Growth
0%
Value
$886B
Holding in Top 10
1,256
Top 10 Change
-21
Top 10 Growth
-2%
Value Growth
-11%
New
90
Increased
1,374
Reduced
1,155
Closed
61
Capital Inflow
$37.8B
Capital Outflow
$32.9B
Net Capital Flow
+$4.9B
Capital Flow Change
+$158M
Calls
$12.1B
Puts
$12.4B
Net Calls
-$274M
Put/Call Ratio
1.02